(Q40552646)

21 September 2017

title

Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. (English)

1 reference

21 September 2017

Janel K Warmka

1

1 reference

21 September 2017

Laura J Mauro

series ordinal

2

1 reference

21 September 2017

Elizabeth V Wattenberg

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

24 May 2004

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

32

1 reference

21 September 2017

page(s)

33085-33092

1 reference

The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Palytoxin acts through Na+,K+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Cell-Type-Specific Activation of p38 Protein Kinase Cascades by the Novel Tumor Promoter Palytoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Functional roles of Akt signaling in mouse skin tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Development of anticancer drugs targeting the MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Regulation of protein kinase cascades by protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Nonreceptor tyrosine phosphatases in cellular signaling: regulation of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

The role of mitogen-activated protein (MAP) kinase in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

Have environmental mutagens caused oncomutations in people?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

The role of protein kinase C in cell surface signal transduction and tumour promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403120200

21 January 2018

Identifiers

DOI

10.1074/JBC.M403120200

1 reference

21 September 2017

1 reference